fda drug safety communication naion semaglutide 2025 Safe use of compounded GLP products fda drug safety communication naion
Description
We stress the need to see a doctor right away if symptoms dont go away or get worse
Some patients with favorable GLP-1 receptor genetic profiles achieve meaningful results at 1mg, while others with less favorable variants may benefit from dose escalation or compounded alternatives
Some patients successfully combine low-dose GLP-1 therapy with alternative pain management
The World Anti-Doping Agency (Wada) has added GLP-1 drugs to its monitoring program, and is in the process of collecting evidence on whether they could be abused by athletes to gain an unfair advantage
